A French clinical-stage company with a ground breaking life-prolonging treatment of pancreatic cancer. Clinical trials Phase 2a to start in early 2024.
AC Biotech is a French biotech start-up company headquartered at the Villejuif Bio Park in Paris.
Our medical objective is to validate and bring to clinical use, a novel approach to improve the treatment of metastatic pancreatic adenocarcinoma.
Archive of publications resulting from our research.